[1] Granado N, Escobedo I, O’Shea E, et al. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice [J]. Synapse,2008, 62(1): 80-84.
[2] Cunha-Oliveira T, Rego AC, Oliveira CR. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs [J]. Brain Res Rev, 2008, 58(1):192-208.
[3] He W, Yan X, Pan S. Amphetamine neurotoxicity in PC12 cells through the PP2A/Akt/GSK3β pathway [J]. Neurotox Res, 2018,34(2), 233-240.
[4] Mines MA, Jope RS. Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice[J]. Cell Signal, 2012, 24:1398-1405.
[5] Chen YCh, Guan YJ, Liu YX, et al. Protective role of AKT-glycogen synthase kinase-3β signaling pathway in the N2a cell with SOD1G93Amutation [J]. Acta Anatomica Sinica, 2016,47(4): 433-441. (in Chinese)
陈燕春, 管英俊, 刘永新, 等. AKT-糖原合成激酶-3β信号通路对SOD1G93A 突变N2a细胞的保护作用[J]. 解剖学报, 2016,47(4): 433-441.
[6] Wu J, Zhu D, Zhang J, et al. Lithium protects against methamphetamine-induced neurotoxicity in PC12 cells via Akt/GSK3β/mTOR pathway[J]. Biochem Biophys Res Commun, 2015, 465(3):368-373.
[7] Jiang H, Guo W, Liang X, et al. Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulator [J]. Cell, 2005, 120(1):123-135.
[8] Sams-Dodd F.Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia[J]. Behav Pharmacol, 1996, 7 (1):3-23.
[9] Hamada N, Fujita Y, Kojima T, et al. MicroRNA expression profiling of NGF-treated PC12 cells revealed a critical role for miR-221 in neuronal differentiation [J]. Neurochem Int,2012, 60(8):743-750.
[10] Bowyer JF, Frame LT, Clausing P, et al. longterm effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats [J]. J Pharmacol Exp Ther, 1998, 286(2):1074-1085.
[11] Seiden LS, Commins DL, Vosmer G, et al. Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections [J].Ann N Y Acad Sci,1988, 537:161-172.
[12] Granado N, Escobedo Ⅰ, O’Shea E, et al. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice [J]. Synapse,2008, 62(1):80-84.
[13] Büttner A. Review: the neuropathology of drug abuse[J]. Neuropathol Appl Neurobiol, 2011, 37(2):118-134.
[14] Cunha-Oliveira T, Rego AC, Oliveira CR. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs[J]. Brain Res Rev, 2008, 58(1): 192-208.
[15] Fang W, Gao G, Zhao H, et al. Role of AKT/GSK-3β/CRMP-2 pathway in axon degeneration of dopaminergic neurons resulting from MPP+ toxicity [J]. Brain Res,2015,1602: 9-19.
[16] Wu Z, Wang G, Wei Y, et al. PI3K/AKT/GSK33β/CRMP-2-mediated neuroplasticity in depression induced by stress [J]. Neuroreport, 2018, 29(15):1256-1263.
[17] Liu L, Sun T, Xin F, et al. Nerve growth factor protects against alcoholinduced neurotoxicity in PC12 cells via PI3K/Akt/mTOR pathway [J]. Alcohol Alcohol, 2017, 52(1):12-18.
[18] Soligo M, Albini M, Bertoli FL, et al. Different responses of PC12 cells to different pro-nerve growth factor protein variants [J].Neurochem Int, 2019, 129:104498.
|